ENASIDENIB MESYLATE

ENASIDENIB MESYLATE was reported 3369 times

ENASIDENIB MESYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IDH DIFFERENTIATION SYNDROME 16 0.7273
1 VASCULAR ACCESS SITE ABSCESS 1 0.3333
2 PRIMARY COUGH HEADACHE 1 0.0588
3 DIFFERENTIATION SYNDROME 43 0.0586
4 ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME 6 0.0288
5 INSTILLATION SITE BURN 1 0.0233
6 INFECTED VARICOSE VEIN 1 0.0213
7 BLAST CELLS 1 0.0192
8 ACUTE MYELOID LEUKAEMIA REFRACTORY 3 0.0174
9 BILIARY CATHETER INSERTION 1 0.0149
10 BLAST CELL COUNT DECREASED 1 0.0137
11 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 16 0.0128
12 RADIATION INFLAMMATION 1 0.0125
13 MUSCLE TENSION DYSPHONIA 1 0.0125
14 MICROCOCCUS INFECTION 1 0.0123
15 HEPATITIS D 1 0.0119
16 EMERGENCY CARE EXAMINATION 8 0.0118
17 BONE MARROW MYELOGRAM ABNORMAL 2 0.0115
18 STITCH ABSCESS 1 0.0105
19 LOWER RESPIRATORY TRACT INFECTION FUNGAL 4 0.0103
20 ADULT FAILURE TO THRIVE 2 0.0094
21 ACUTE MYELOID LEUKAEMIA RECURRENT 20 0.0093
22 CORNEAL INFECTION 2 0.0092
23 DACRYOCANALICULITIS 1 0.0085
24 CLOSTRIDIAL SEPSIS 2 0.0083
25 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 1 0.0082
26 BONE MARROW RETICULIN FIBROSIS 2 0.0078
27 BLAST CELL COUNT INCREASED 8 0.0076
28 ENDOMETRIAL CANCER RECURRENT 1 0.0076
29 ACUTE MYELOID LEUKAEMIA 119 0.0076
30 CORNEAL DEFECT 1 0.0076
31 LEUKOSTASIS SYNDROME 1 0.0075
32 VAGINAL CYST 2 0.0074
33 HYPERACTIVE PHARYNGEAL REFLEX 1 0.0069
34 BLOOD FOLATE INCREASED 1 0.0060
35 MYELOID LEUKAEMIA 3 0.0060
36 BOREDOM 2 0.0059
37 CATHETER SITE ABSCESS 1 0.0057
38 NASAL SINUS CANCER 1 0.0053
39 BONE SARCOMA 1 0.0052
40 ORAL BLOOD BLISTER 1 0.0050
41 BLOOD URIC ACID ABNORMAL 2 0.0049
42 LIP INFECTION 1 0.0047
43 TRANSFUSION REACTION 4 0.0046
44 PLATELET DISORDER 11 0.0044
45 NEUTROPHIL COUNT ABNORMAL 12 0.0042
46 HAEMOGLOBIN ABNORMAL 26 0.0040
47 MICROCYTOSIS 1 0.0040
48 FULL BLOOD COUNT DECREASED 81 0.0040
49 ANORECTAL INFECTION 1 0.0040
50 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 1 0.0039
51 HYPERLEUKOCYTOSIS 3 0.0034
52 CHANGE IN SUSTAINED ATTENTION 1 0.0033
53 ASPERGILLUS TEST POSITIVE 1 0.0032
54 LEUKAEMIA 30 0.0032
55 CORNEAL PERFORATION 2 0.0032
56 VARICOSE VEIN RUPTURED 1 0.0031
57 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 2 0.0030
58 VIRAL DIARRHOEA 1 0.0029
59 BLOOD BILIRUBIN UNCONJUGATED INCREASED 2 0.0028
60 CHOLANGIOCARCINOMA 4 0.0027
61 BONE MARROW DISORDER 8 0.0026
62 DROPPED HEAD SYNDROME 1 0.0025
63 FULL BLOOD COUNT INCREASED 3 0.0025
64 RED BLOOD CELL TRANSFUSION 1 0.0024
65 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 1 0.0024
66 GENE MUTATION IDENTIFICATION TEST POSITIVE 1 0.0024
67 VOLUME BLOOD DECREASED 1 0.0024
68 COLONIC ABSCESS 2 0.0023
69 PLATELET COUNT ABNORMAL 13 0.0021
70 BLAST CELLS PRESENT 1 0.0021
71 ONCOLOGIC COMPLICATION 2 0.0021
72 SALIVARY GLAND CANCER 1 0.0020
73 TRANSURETHRAL PROSTATECTOMY 1 0.0020
74 RESPIRATORY TRACT INFECTION FUNGAL 1 0.0019
75 MEASLES 1 0.0019
76 GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0018
77 LEUKAEMIA RECURRENT 3 0.0018
78 NAIL BED BLEEDING 1 0.0018
79 WHITE BLOOD CELL COUNT ABNORMAL 11 0.0017
80 LACRIMAL DISORDER 1 0.0017
81 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
82 PLASMA CELL LEUKAEMIA 1 0.0017
83 CEREBRAL ASPERGILLOSIS 1 0.0016
84 TASTE DISORDER 33 0.0016
85 PSOAS ABSCESS 1 0.0016
86 ARTERITIS 1 0.0016
87 BONE MARROW TRANSPLANT 3 0.0016
88 BLOOD URIC ACID INCREASED 9 0.0016
89 SPINAL CORD INFECTION 1 0.0015
90 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
91 LIP EXFOLIATION 2 0.0015
92 NASAL OPERATION 1 0.0015
93 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
94 PERIODONTAL DISEASE 2 0.0014
95 NOROVIRUS INFECTION 2 0.0014
96 RED BLOOD CELL COUNT ABNORMAL 2 0.0014
97 TRAUMATIC FRACTURE 1 0.0014
98 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
99 GINGIVAL ABSCESS 1 0.0013
100 DAYDREAMING 2 0.0013
101 CRITICAL ILLNESS 1 0.0013
102 IMPLANT SITE EXTRAVASATION 1 0.0013
103 PNEUMONIA FUNGAL 5 0.0013
104 BLOOD BILIRUBIN INCREASED 34 0.0013
105 PLATELET COUNT DECREASED 133 0.0012
106 ENTEROCOCCAL SEPSIS 1 0.0012
107 FULL BLOOD COUNT ABNORMAL 13 0.0012
108 HAEMATOLOGICAL INFECTION 3 0.0012
109 HOSPITALISATION 186 0.0012
110 PSEUDOMONAL BACTERAEMIA 1 0.0012
111 INTENTIONAL DEVICE USE ISSUE 1 0.0012
112 VITAL FUNCTIONS ABNORMAL 1 0.0012
113 RED BLOOD CELL COUNT DECREASED 33 0.0012
114 SPINAL CORD NEOPLASM 1 0.0011
115 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
116 TUMOUR LYSIS SYNDROME 10 0.0011
117 NASAL DISORDER 3 0.0011
118 WHITE BLOOD CELL DISORDER 3 0.0011
119 DISTURBANCE IN SEXUAL AROUSAL 1 0.0011
120 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
121 NEUTROPENIC INFECTION 1 0.0010
122 PROSTATE INFECTION 1 0.0010
123 HYPOGEUSIA 2 0.0010
124 DEVICE RELATED THROMBOSIS 1 0.0010
125 ULNA FRACTURE 1 0.0010
126 ONYCHALGIA 1 0.0010
127 RECURRENT CANCER 4 0.0010
128 GASTRIC PH DECREASED 1 0.0010
129 PRODUCT COMMINGLING 1 0.0009
130 IRON OVERLOAD 1 0.0009
131 STREPTOCOCCAL BACTERAEMIA 1 0.0009
132 INFECTION SUSCEPTIBILITY INCREASED 2 0.0009
133 CORNEAL DISORDER 2 0.0009
134 SUBCLAVIAN VEIN THROMBOSIS 1 0.0009
135 BLOOD DISORDER 7 0.0009
136 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
137 PNEUMONIA INFLUENZAL 1 0.0008
138 OXYGEN CONSUMPTION INCREASED 2 0.0008
139 ESCHERICHIA TEST POSITIVE 1 0.0008
140 BONE LESION 3 0.0008
141 WHITE BLOOD CELL COUNT INCREASED 31 0.0008
142 DEATH 682 0.0008
143 TESTICULAR SWELLING 1 0.0008
144 SEROMA 1 0.0008
145 BLOOD BILIRUBIN ABNORMAL 1 0.0008
146 OBSTRUCTION GASTRIC 1 0.0008
147 PLATELET TRANSFUSION 1 0.0008
148 FEELINGS OF WORTHLESSNESS 1 0.0008
149 WEIGHT BEARING DIFFICULTY 2 0.0007
150 EFFUSION 1 0.0007
151 BLOOD COUNT ABNORMAL 11 0.0007
152 PLEURITIC PAIN 2 0.0007
153 BILIARY TRACT DISORDER 1 0.0007
154 BLOOD TEST ABNORMAL 10 0.0007
155 AUDITORY DISORDER 1 0.0007
156 INTENSIVE CARE 1 0.0007
157 WHITE BLOOD CELL COUNT DECREASED 76 0.0007
158 PRECANCEROUS SKIN LESION 1 0.0007
159 BLOOD CREATINE INCREASED 3 0.0007
160 CRANIOCEREBRAL INJURY 2 0.0007
161 GINGIVAL HYPERTROPHY 1 0.0007
162 DYSCHEZIA 2 0.0007
163 CYTOPENIA 8 0.0007
164 RENAL FUNCTION TEST ABNORMAL 3 0.0006
165 EYE ALLERGY 1 0.0006
166 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
167 AORTIC VALVE DISEASE 1 0.0006
168 CORONAVIRUS INFECTION 4 0.0006
169 HEPATIC ENZYME ABNORMAL 3 0.0006
170 SLEEP TALKING 1 0.0006
171 GLIOBLASTOMA 1 0.0006
172 WOUND INFECTION STAPHYLOCOCCAL 1 0.0006
173 HAEMOGLOBIN DECREASED 58 0.0006
174 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
175 LIVER FUNCTION TEST INCREASED 12 0.0006
176 GRAFT VERSUS HOST DISEASE 4 0.0006
177 OPHTHALMIC HERPES ZOSTER 1 0.0006
178 CHEILITIS 3 0.0006
179 MONOCYTE COUNT INCREASED 2 0.0006
180 ESSENTIAL HYPERTENSION 1 0.0005
181 THROMBOCYTOSIS 2 0.0005
182 PNEUMONIA KLEBSIELLA 1 0.0005
183 CATHETER PLACEMENT 1 0.0005
184 SMALL INTESTINAL PERFORATION 1 0.0005
185 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
186 FACE INJURY 2 0.0005
187 HAEMATOTOXICITY 5 0.0005
188 GASTRIC INFECTION 2 0.0005
189 DECREASED APPETITE 121 0.0005
190 ORAL INFECTION 2 0.0005
191 CELL DEATH 1 0.0005
192 ADVERSE EVENT 46 0.0005
193 ORGAN FAILURE 2 0.0005
194 RENAL HAEMORRHAGE 1 0.0005
195 NEUTROPHIL COUNT DECREASED 20 0.0005
196 ARTHRITIS BACTERIAL 2 0.0005
197 HYPERBILIRUBINAEMIA 5 0.0005
198 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
199 BODY TEMPERATURE FLUCTUATION 1 0.0005
200 LABORATORY TEST ABNORMAL 14 0.0005
201 IMMUNODEFICIENCY 7 0.0005
202 INCOHERENT 3 0.0005
203 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
204 BONE CANCER 2 0.0005
205 PERICARDIAL HAEMORRHAGE 1 0.0005
206 LIMB MASS 1 0.0005
207 FEAR OF DEATH 1 0.0004
208 URINARY TRACT DISORDER 2 0.0004
209 AGEUSIA 11 0.0004
210 ONYCHOCLASIS 3 0.0004
211 BLOOD POTASSIUM DECREASED 13 0.0004
212 YELLOW SKIN 2 0.0004
213 SKIN ABRASION 2 0.0004
214 MYOPIA 1 0.0004
215 SUBDURAL HAEMATOMA 6 0.0004
216 PANNICULITIS 1 0.0004
217 MOUTH HAEMORRHAGE 3 0.0004
218 RENAL DISORDER 19 0.0004
219 CEREBRAL DISORDER 3 0.0004
220 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
221 INFREQUENT BOWEL MOVEMENTS 1 0.0004
222 STEM CELL TRANSPLANT 1 0.0004
223 HAEMORRHAGE URINARY TRACT 1 0.0004
224 CATHETER SITE PAIN 1 0.0004
225 PLATELET COUNT INCREASED 5 0.0004
226 ADVERSE DRUG REACTION 34 0.0004
227 FURUNCLE 3 0.0004
228 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
229 BLOOD POTASSIUM ABNORMAL 1 0.0004
230 YAWNING 1 0.0004
231 JAUNDICE 10 0.0004
232 BACK DISORDER 6 0.0004
233 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
234 ORAL FUNGAL INFECTION 1 0.0004
235 ULCERATIVE KERATITIS 1 0.0004
236 FAECALOMA 2 0.0004
237 GASTROINTESTINAL PAIN 4 0.0004
238 RED BLOOD CELL COUNT INCREASED 1 0.0004
239 MACULE 1 0.0004
240 CHOLECYSTITIS INFECTIVE 1 0.0004
241 BONE PAIN 21 0.0004
242 PANCYTOPENIA 20 0.0004
243 DRUG TOLERANCE DECREASED 1 0.0004
244 SKIN HYPERTROPHY 1 0.0004
245 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
246 BLOOD PRESSURE ABNORMAL 7 0.0004
247 HAEMATOLOGICAL MALIGNANCY 1 0.0004
248 INTERNAL HAEMORRHAGE 4 0.0003
249 HYPERSOMNIA 10 0.0003
250 VITAMIN B12 DECREASED 1 0.0003
251 MYELODYSPLASTIC SYNDROME 5 0.0003
252 ESCHERICHIA SEPSIS 1 0.0003
253 PULMONARY PAIN 1 0.0003
254 ILLNESS 35 0.0003
255 COVID-19 PNEUMONIA 4 0.0003
256 BACTERAEMIA 4 0.0003
257 GASTROINTESTINAL INFECTION 3 0.0003
258 GOUT 6 0.0003
259 ATYPICAL PNEUMONIA 1 0.0003
260 ANAL INCONTINENCE 3 0.0003
261 LUNG ADENOCARCINOMA 1 0.0003
262 FEBRILE NEUTROPENIA 22 0.0003
263 CENTRAL VENOUS CATHETERISATION 1 0.0003
264 BLOOD BLISTER 1 0.0003
265 FOREIGN BODY IN THROAT 1 0.0003
266 BREAST CANCER RECURRENT 1 0.0003
267 BACTERIAL SEPSIS 1 0.0003
268 ASPERGILLUS INFECTION 2 0.0003
269 INFUSION SITE HAEMORRHAGE 1 0.0003
270 SUSPECTED COVID-19 1 0.0003
271 SINUS DISORDER 6 0.0003
272 BLADDER DISORDER 3 0.0003
273 APPETITE DISORDER 2 0.0003
274 TERMINAL STATE 2 0.0003
275 PLANTAR FASCIITIS 1 0.0003
276 CEREBRAL HAEMATOMA 1 0.0003
277 LIVER DISORDER 13 0.0003
278 RESPIRATION ABNORMAL 2 0.0003
279 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
280 BLOOD CREATININE ABNORMAL 1 0.0003
281 CONSTIPATION 63 0.0003
282 MICTURITION DISORDER 1 0.0003
283 LARGE INTESTINE PERFORATION 2 0.0003
284 FATIGUE 224 0.0003
285 HANGOVER 1 0.0003
286 NECROTISING FASCIITIS 1 0.0003
287 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
288 SEASONAL ALLERGY 4 0.0003
289 GLOSSITIS 1 0.0003
290 OFF LABEL USE 246 0.0003
291 HAEMORRHAGIC DIATHESIS 1 0.0003
292 DECREASED ACTIVITY 3 0.0003
293 INFECTION 40 0.0003
294 VIRAL INFECTION 9 0.0003
295 NEURODERMATITIS 1 0.0003
296 SKIN INFECTION 3 0.0003
297 PRODUCT STORAGE ISSUE 1 0.0003
298 TROPONIN INCREASED 2 0.0003
299 DEVICE RELATED INFECTION 4 0.0003
300 REHABILITATION THERAPY 1 0.0003
301 CERVIX CARCINOMA 1 0.0003
302 BRAIN FOG 4 0.0003
303 MULTIPLE ALLERGIES 2 0.0003
304 NAIL DISCOLOURATION 1 0.0003
305 CEREBRAL HAEMORRHAGE 9 0.0003
306 OESOPHAGEAL CANDIDIASIS 1 0.0003
307 SKIN PAPILLOMA 1 0.0002
308 NAUSEA 197 0.0002
309 TRIGEMINAL NEURALGIA 1 0.0002
310 LOCALISED INFECTION 6 0.0002
311 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
312 POST PROCEDURAL INFECTION 2 0.0002
313 ASTHENIA 92 0.0002
314 ABNORMAL FAECES 2 0.0002
315 DEMYELINATION 1 0.0002
316 HYPERURICAEMIA 1 0.0002
317 ESCHERICHIA INFECTION 2 0.0002
318 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
319 CONGESTIVE CARDIOMYOPATHY 1 0.0002
320 UNEVALUABLE EVENT 18 0.0002
321 FACE OEDEMA 4 0.0002
322 MUSCLE FATIGUE 1 0.0002
323 ABSCESS LIMB 1 0.0002
324 CARDIAC FAILURE CHRONIC 1 0.0002
325 PERIPHERAL SWELLING 36 0.0002
326 BLOOD MAGNESIUM DECREASED 2 0.0002
327 STOMATITIS 14 0.0002
328 SEPTIC SHOCK 10 0.0002
329 SARS-COV-2 TEST POSITIVE 3 0.0002
330 IMMUNOSUPPRESSION 2 0.0002
331 HEAD DISCOMFORT 4 0.0002
332 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
333 SEPSIS 25 0.0002
334 MYOSITIS 2 0.0002
335 CHROMATURIA 5 0.0002
336 HEAD INJURY 7 0.0002
337 LEUKOCYTOSIS 4 0.0002
338 VASCULAR DEVICE INFECTION 1 0.0002
339 LIP DRY 2 0.0002
340 DIARRHOEA 142 0.0002
341 HAEMOGLOBIN INCREASED 1 0.0002
342 ABDOMINAL HERNIA 1 0.0002
343 DISEASE COMPLICATION 1 0.0002
344 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
345 CHRONIC MYELOID LEUKAEMIA 1 0.0002
346 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
347 LOCALISED OEDEMA 1 0.0002
348 MASS 3 0.0002
349 PRODUCT DOSE OMISSION 14 0.0002
350 FEELING OF DESPAIR 1 0.0002
351 UMBILICAL HERNIA 1 0.0002
352 PYREXIA 74 0.0002
353 SKIN TIGHTNESS 1 0.0002
354 BLOOD SODIUM DECREASED 4 0.0002
355 HEPATOCELLULAR INJURY 3 0.0002
356 SARCOIDOSIS 1 0.0002
357 CARDIAC TAMPONADE 1 0.0002
358 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
359 PNEUMONIA 68 0.0002
360 GUILLAIN-BARRE SYNDROME 1 0.0002
361 DIZZINESS POSTURAL 2 0.0002
362 HORMONE LEVEL ABNORMAL 1 0.0002
363 LUNG DISORDER 10 0.0002
364 HYPERVOLAEMIA 1 0.0002
365 DYSGEUSIA 15 0.0002
366 PULMONARY MASS 3 0.0002
367 SALIVARY HYPERSECRETION 2 0.0002
368 KLEBSIELLA INFECTION 1 0.0002
369 DYSPHORIA 1 0.0002
370 BONE MARROW FAILURE 4 0.0002
371 FLUID RETENTION 10 0.0002
372 FEMORAL NECK FRACTURE 1 0.0002
373 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
374 DISEASE PROGRESSION 23 0.0002
375 FAILURE TO THRIVE 1 0.0002
376 TRANSFUSION 2 0.0002
377 SERUM FERRITIN INCREASED 1 0.0002
378 FOOD POISONING 1 0.0002
379 SKIN LESION 5 0.0002
380 PROSTATIC DISORDER 1 0.0002
381 DIVERTICULITIS 5 0.0002
382 ON AND OFF PHENOMENON 1 0.0002
383 SKIN DISORDER 6 0.0002
384 STREPTOCOCCAL INFECTION 1 0.0002
385 INTRACRANIAL PRESSURE INCREASED 1 0.0002
386 HEART RATE ABNORMAL 1 0.0002
387 DEMENTIA 5 0.0002
388 THROMBOCYTOPENIA 20 0.0002
389 MALNUTRITION 2 0.0002
390 ORAL PAIN 4 0.0002
391 EXERCISE TOLERANCE DECREASED 1 0.0002
392 SKIN ATROPHY 1 0.0002
393 METABOLIC DISORDER 1 0.0002
394 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
395 BRADYKINESIA 1 0.0002
396 GALLBLADDER DISORDER 3 0.0002
397 ODYNOPHAGIA 1 0.0002
398 WRIST FRACTURE 2 0.0002
399 GASTROENTERITIS VIRAL 3 0.0002
400 HEPATITIS B 1 0.0002
401 HEPATITIS C 2 0.0002
402 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
403 HYPOACUSIS 7 0.0002
404 ARTHROPATHY 9 0.0002
405 INFLUENZA 18 0.0002
406 HEPATIC ENZYME INCREASED 11 0.0002
407 CYST 2 0.0002
408 ABDOMINAL DISCOMFORT 27 0.0002
409 BACTERIAL INFECTION 3 0.0002
410 EPISTAXIS 12 0.0002
411 DRY MOUTH 13 0.0002
412 COVID-19 28 0.0002
413 PHOTOPSIA 1 0.0002
414 BLOOD URINE PRESENT 3 0.0002
415 HAEMATEMESIS 4 0.0002
416 NEUROPATHY PERIPHERAL 15 0.0002
417 FEELING JITTERY 3 0.0002
418 JOINT SWELLING 19 0.0002
419 HEPATIC CYTOLYSIS 2 0.0002
420 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
421 CHOLESTASIS 3 0.0002
422 HIP FRACTURE 5 0.0002
423 ERUCTATION 3 0.0002
424 RASH GENERALISED 4 0.0002
425 ORAL CANDIDIASIS 2 0.0002
426 PRODUCT FORMULATION ISSUE 1 0.0002
427 WEIGHT DECREASED 42 0.0002
428 EYE HAEMORRHAGE 2 0.0001
429 SKIN MASS 1 0.0001
430 GAIT INABILITY 5 0.0001
431 MALIGNANT NEOPLASM PROGRESSION 15 0.0001
432 COUGH 41 0.0001
433 INFARCTION 1 0.0001
434 NEPHROTIC SYNDROME 1 0.0001
435 GASTRIC DISORDER 5 0.0001
436 JOINT EFFUSION 1 0.0001
437 LYMPHOEDEMA 1 0.0001
438 POLLAKIURIA 6 0.0001
439 DEFAECATION URGENCY 1 0.0001
440 BLINDNESS UNILATERAL 2 0.0001
441 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
442 EATING DISORDER 3 0.0001
443 NEUTROPENIA 19 0.0001
444 CARDIAC DISORDER 13 0.0001
445 ANOSMIA 2 0.0001
446 LIVER FUNCTION TEST ABNORMAL 4 0.0001
447 FAECES SOFT 1 0.0001
448 FLUID OVERLOAD 2 0.0001
449 DYSPHAGIA 13 0.0001
450 SENSITIVE SKIN 1 0.0001
451 BLOOD PRESSURE DECREASED 9 0.0001
452 CARDIOMYOPATHY 2 0.0001
453 SKIN HAEMORRHAGE 2 0.0001
454 TOOTH DISORDER 3 0.0001
455 COLON CANCER 2 0.0001
456 VOMITING 63 0.0001
457 PULMONARY OEDEMA 6 0.0001
458 GASTROINTESTINAL DISORDER 12 0.0001
459 RASH PAPULAR 3 0.0001
460 THERAPY NON-RESPONDER 6 0.0001
461 HYPOAESTHESIA ORAL 2 0.0001
462 DEPRESSED MOOD 7 0.0001
463 DYSPEPSIA 13 0.0001
464 AORTIC ANEURYSM 1 0.0001
465 HYPERTHERMIA 1 0.0001
466 NEPHROLITHIASIS 6 0.0001
467 BOWEL MOVEMENT IRREGULARITY 1 0.0001
468 PERICARDIAL EFFUSION 3 0.0001
469 THYROID DISORDER 2 0.0001
470 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
471 HAEMORRHAGIC STROKE 1 0.0001
472 GASTROINTESTINAL INFLAMMATION 1 0.0001
473 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
474 ABDOMINAL PAIN UPPER 26 0.0001
475 FALL 42 0.0001
476 ULCER 2 0.0001
477 RASH ERYTHEMATOUS 6 0.0001
478 SCIATICA 2 0.0001
479 BLOOD PRESSURE FLUCTUATION 3 0.0001
480 DRUG INTOLERANCE 12 0.0001
481 SENSORY LOSS 1 0.0001
482 RHINITIS 1 0.0001
483 DECUBITUS ULCER 1 0.0001
484 POLYURIA 1 0.0001
485 EYE DISORDER 4 0.0001
486 MUSCLE INJURY 1 0.0001
487 FUNGAL INFECTION 4 0.0001
488 PERICARDITIS 2 0.0001
489 DYSPNOEA 67 0.0001
490 CIRCULATORY COLLAPSE 2 0.0001
491 HEPATITIS 3 0.0001
492 MYOPATHY 1 0.0001
493 ORTHOSTATIC HYPOTENSION 2 0.0001
494 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
495 HAEMORRHAGE 12 0.0001
496 MUSCULAR WEAKNESS 13 0.0001
497 JOINT STIFFNESS 3 0.0001
498 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
499 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
500 PURPURA 1 0.0001
501 ATRIAL FIBRILLATION 11 0.0001
502 DRUG ERUPTION 2 0.0001
503 DIZZINESS 56 0.0001
504 PRODUCT DOSE OMISSION ISSUE 33 0.0001
505 CARDIOTOXICITY 1 0.0001
506 RESPIRATORY DISTRESS 3 0.0001
507 DYSURIA 4 0.0001
508 UROSEPSIS 1 0.0001
509 NERVE COMPRESSION 1 0.0001
510 FEELING COLD 3 0.0001
511 HAEMOPTYSIS 3 0.0001
512 RENAL IMPAIRMENT 9 0.0001
513 APPENDICITIS 1 0.0001
514 SWELLING 10 0.0001
515 SPINAL DISORDER 1 0.0001
516 GASTRIC ULCER 2 0.0001
517 INSOMNIA 28 0.0001
518 DEHYDRATION 14 0.0001
519 HYPOTENSION 21 0.0001
520 LOWER LIMB FRACTURE 2 0.0001
521 ATELECTASIS 1 0.0001
522 NASOPHARYNGITIS 19 0.0001
523 VITAMIN D DEFICIENCY 1 0.0001
524 CHOKING 2 0.0001
525 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
526 HEPATOMEGALY 1 0.0001
527 HOSPICE CARE 1 0.0001
528 LIGAMENT SPRAIN 1 0.0001
529 RASH 44 0.0001
530 INABILITY TO AFFORD MEDICATION 1 0.0001
531 RESPIRATORY DISORDER 3 0.0001
532 HYPOTONIA 1 0.0001
533 ANAEMIA 19 0.0001
534 APHASIA 3 0.0001
535 SOMNOLENCE 20 0.0001
536 SLEEP DISORDER 7 0.0001
537 PLEURAL EFFUSION 6 0.0001
538 WEIGHT INCREASED 22 0.0001
539 TOOTH ABSCESS 1 0.0001
540 MALAISE 43 0.0001
541 BODY TEMPERATURE INCREASED 2 0.0001
542 NEUTROPHIL COUNT INCREASED 1 0.0001
543 INITIAL INSOMNIA 1 0.0001
544 EAR DISCOMFORT 1 0.0001
545 EMOTIONAL DISORDER 3 0.0001
546 LIMB DISCOMFORT 3 0.0001
547 PRURITUS 37 0.0001
548 PULMONARY HYPERTENSION 2 0.0001
549 PETECHIAE 1 0.0001
550 WEIGHT FLUCTUATION 1 0.0001
551 BRADYCARDIA 5 0.0001
552 CYSTITIS 3 0.0001
553 NIGHT SWEATS 3 0.0001
554 POOR QUALITY SLEEP 2 0.0001
555 SKIN CANCER 2 0.0001
556 CONFUSIONAL STATE 15 0.0001
557 BALANCE DISORDER 8 0.0001
558 RASH PRURITIC 5 0.0001
559 FAECES DISCOLOURED 2 0.0001
560 BACK INJURY 1 0.0001
561 PRODUCT DISPENSING ERROR 2 0.0001
562 PULMONARY THROMBOSIS 1 0.0001
563 CHOLELITHIASIS 3 0.0001
564 TREATMENT NONCOMPLIANCE 5 0.0001
565 ASPIRATION 1 0.0001
566 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
567 STAPHYLOCOCCAL INFECTION 3 0.0001
568 DENTAL CARIES 1 0.0001
569 OEDEMA PERIPHERAL 11 0.0001
570 LIP SWELLING 3 0.0001
571 NERVE INJURY 1 0.0001
572 URINARY RETENTION 3 0.0001
573 HYPERTENSIVE CRISIS 1 0.0001
574 HEPATOTOXICITY 2 0.0001
575 INTESTINAL PERFORATION 1 0.0001
576 FISTULA 1 0.0001
577 BLOOD CALCIUM DECREASED 1 0.0001
578 GAIT DISTURBANCE 17 0.0001
579 EYE INFECTION 1 0.0001
580 FLATULENCE 5 0.0001
581 SCAB 1 0.0001
582 MICTURITION URGENCY 1 0.0001
583 CARDIAC FAILURE 7 0.0001
584 TINNITUS 4 0.0001
585 HERPES ZOSTER 5 0.0001
586 NEOPLASM 1 0.0001
587 LETHARGY 5 0.0001
588 GASTRIC HAEMORRHAGE 1 0.0001
589 METASTASES TO LUNG 1 0.0001
590 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
591 MADAROSIS 1 0.0001
592 SPLENOMEGALY 1 0.0001
593 SPINAL PAIN 1 0.0001
594 PAIN IN EXTREMITY 25 0.0001
595 LYMPHADENOPATHY 3 0.0001
596 BLOOD IRON DECREASED 1 0.0001
597 ARTHRALGIA 35 0.0001
598 MACULAR DEGENERATION 1 0.0001
599 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
600 HEPATIC CANCER 2 0.0001
601 RENAL FAILURE 11 0.0001
602 DRY SKIN 11 0.0001
603 RESPIRATORY FAILURE 6 0.0001
604 NEURALGIA 2 0.0001
605 LIVER INJURY 2 0.0001
606 BRONCHITIS 6 0.0001
607 TENDON RUPTURE 1 0.0001
608 PHARYNGITIS 1 0.0001
609 HEADACHE 50 0.0001
610 DEPRESSION 18 0.0001
611 MUSCLE ATROPHY 1 0.0001
612 HYPOPHAGIA 2 0.0001
613 DRUG INEFFECTIVE 102 0.0001
614 SKIN ULCER 2 0.0001
615 RHINORRHOEA 5 0.0001
616 HAEMATOMA 2 0.0001
617 RESPIRATORY TRACT INFECTION 2 0.0001
618 CEREBROVASCULAR ACCIDENT 13 0.0001
619 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
620 ABDOMINAL DISTENSION 8 0.0001
621 NODULE 1 0.0001
622 MUSCULOSKELETAL PAIN 4 0.0001
623 ARTHRITIS 6 0.0001
624 TOOTH INFECTION 1 0.0001
625 PULMONARY CONGESTION 1 0.0001
626 CHEST PAIN 14 0.0001
627 ADVERSE REACTION 1 0.0001
628 NEOPLASM MALIGNANT 5 0.0001
629 BREAST CANCER FEMALE 2 0.0001
630 THROMBOSIS 6 0.0001
631 QUALITY OF LIFE DECREASED 1 0.0001
632 FREQUENT BOWEL MOVEMENTS 2 0.0001
633 OEDEMA 4 0.0001
634 HYPOAESTHESIA 11 0.0001
635 HUNGER 1 0.0001
636 APHONIA 1 0.0001
637 NECK PAIN 4 0.0001
638 SKIN EXFOLIATION 6 0.0001
639 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
640 SKIN REACTION 1 0.0001
641 URINARY TRACT INFECTION 12 0.0001
642 THERAPY INTERRUPTED 5 0.0001
643 PARALYSIS 1 0.0001
644 GASTROENTERITIS 1 0.0001
645 CHEST DISCOMFORT 7 0.0001
646 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
647 LACRIMATION INCREASED 2 0.0001
648 INSURANCE ISSUE 1 0.0001
649 SKIN DISCOLOURATION 3 0.0001
650 LYMPHOMA 1 0.0001
651 EJECTION FRACTION DECREASED 1 0.0001
652 COGNITIVE DISORDER 3 0.0001
653 PRODUCT USE ISSUE 12 0.0001
654 CYANOSIS 1 0.0001
655 DISEASE RECURRENCE 3 0.0001
656 DRUG INTERACTION 10 0.0001
657 RESPIRATORY TRACT CONGESTION 1 0.0001
658 HYPOTHYROIDISM 2 0.0001
659 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
660 MUSCLE TIGHTNESS 1 0.0001
661 BLOOD POTASSIUM INCREASED 1 0.0001
662 INFLUENZA LIKE ILLNESS 5 0.0001
663 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
664 DRUG LEVEL INCREASED 1 0.0001
665 BACK PAIN 14 0.0001
666 PAIN 37 0.0001
667 LEUKOPENIA 3 0.0001
668 EYE PRURITUS 2 0.0001
669 ANGER 2 0.0001
670 HAEMATURIA 2 0.0001
671 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
672 MEMORY IMPAIRMENT 8 0.0001
673 DELIRIUM 2 0.0001
674 PARAESTHESIA 9 0.0001
675 RASH MACULAR 2 0.0001
676 PRODUCT STORAGE ERROR 5 0.0001
677 EOSINOPHILIA 1 0.0001
678 HEART RATE DECREASED 2 0.0001
679 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
680 ISCHAEMIC STROKE 1 0.0001
681 THIRST 1 0.0001
682 MOBILITY DECREASED 4 0.0001
683 RESTLESS LEGS SYNDROME 1 0.0001
684 BONE DISORDER 1 0.0001
685 HAEMATOCHEZIA 3 0.0001
686 CONJUNCTIVITIS 1 0.0001
687 DYSPNOEA EXERTIONAL 2 0.0001
688 HALLUCINATION 4 0.0001
689 COLITIS 2 0.0001
690 SLEEP APNOEA SYNDROME 1 0.0001
691 PULMONARY FIBROSIS 1 0.0001
692 ACUTE RESPIRATORY FAILURE 1 0.0001
693 CONTUSION 5 0.0001
694 HERNIA 1 0.0001
695 EAR PAIN 1 0.0001
696 ORAL HERPES 1 0.0001
697 CHILLS 6 0.0001
698 NASAL CONGESTION 3 0.0001
699 ALOPECIA 10 0.0001
700 DISORIENTATION 2 0.0001
701 CATARACT 3 0.0001
702 PRESCRIBED UNDERDOSE 1 0.0001
703 PREGNANCY 1 0.0000
704 CARDIAC FAILURE CONGESTIVE 4 0.0000
705 FEELING HOT 3 0.0000
706 LUNG NEOPLASM MALIGNANT 2 0.0000
707 VISUAL IMPAIRMENT 6 0.0000
708 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
709 DERMATITIS 1 0.0000
710 MOUTH ULCERATION 1 0.0000
711 HYPERTENSION 10 0.0000
712 RETCHING 1 0.0000
713 LOSS OF CONSCIOUSNESS 6 0.0000
714 IRRITABLE BOWEL SYNDROME 1 0.0000
715 RECTAL HAEMORRHAGE 2 0.0000
716 PRURITUS GENERALISED 1 0.0000
717 AMNESIA 3 0.0000
718 SWELLING FACE 3 0.0000
719 BLOOD CREATININE INCREASED 3 0.0000
720 PRODUCT PRESCRIBING ISSUE 1 0.0000
721 BLOOD PRESSURE INCREASED 7 0.0000
722 ACUTE KIDNEY INJURY 7 0.0000
723 TRANSAMINASES INCREASED 1 0.0000
724 GLOSSODYNIA 1 0.0000
725 HEART RATE IRREGULAR 1 0.0000
726 OROPHARYNGEAL PAIN 4 0.0000
727 OCULAR HYPERAEMIA 2 0.0000
728 PRODUCT PRESCRIBING ERROR 1 0.0000
729 URTICARIA 7 0.0000
730 BLOOD GLUCOSE DECREASED 2 0.0000
731 INTERSTITIAL LUNG DISEASE 2 0.0000
732 MENTAL IMPAIRMENT 1 0.0000
733 FIBROMYALGIA 1 0.0000
734 PRESYNCOPE 1 0.0000
735 DRY EYE 2 0.0000
736 CELLULITIS 2 0.0000
737 CARDIOVASCULAR DISORDER 1 0.0000
738 INFLAMMATION 2 0.0000
739 EXPOSURE VIA SKIN CONTACT 1 0.0000
740 DIPLOPIA 1 0.0000
741 NERVOUSNESS 2 0.0000
742 DEAFNESS 1 0.0000
743 SPEECH DISORDER 2 0.0000
744 FEELING ABNORMAL 9 0.0000
745 FEAR 1 0.0000
746 PNEUMONITIS 1 0.0000
747 MOOD ALTERED 1 0.0000
748 VISION BLURRED 5 0.0000
749 TREMOR 6 0.0000
750 PROCEDURAL PAIN 1 0.0000
751 MENTAL STATUS CHANGES 1 0.0000
752 WOUND 1 0.0000
753 BLISTER 2 0.0000
754 MYALGIA 6 0.0000
755 INTENTIONAL DOSE OMISSION 1 0.0000
756 SEIZURE 4 0.0000
757 MYOCARDIAL INFARCTION 6 0.0000
758 DYSSTASIA 1 0.0000
759 MUSCULOSKELETAL STIFFNESS 3 0.0000
760 ASCITES 1 0.0000
761 THERAPEUTIC RESPONSE DECREASED 2 0.0000
762 DISCOMFORT 2 0.0000
763 DRUG ADMINISTRATION ERROR 1 0.0000
764 FEMUR FRACTURE 1 0.0000
765 SWOLLEN TONGUE 1 0.0000
766 BLOOD GLUCOSE INCREASED 6 0.0000
767 ANXIETY 9 0.0000
768 MOOD SWINGS 1 0.0000
769 METABOLIC ACIDOSIS 1 0.0000
770 HYPERHIDROSIS 4 0.0000
771 HEART RATE INCREASED 3 0.0000
772 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
773 SYNCOPE 3 0.0000
774 TYPE 2 DIABETES MELLITUS 1 0.0000
775 FLUSHING 3 0.0000
776 SINUSITIS 3 0.0000
777 HYPOXIA 1 0.0000
778 MYELOSUPPRESSION 1 0.0000
779 HYPERGLYCAEMIA 1 0.0000
780 MUSCLE SPASMS 5 0.0000
781 AGITATION 2 0.0000
782 HYPERSENSITIVITY 5 0.0000
783 HEPATIC FUNCTION ABNORMAL 1 0.0000
784 HOT FLUSH 2 0.0000
785 INTESTINAL OBSTRUCTION 1 0.0000
786 ABDOMINAL PAIN 6 0.0000
787 PALPITATIONS 3 0.0000
788 EMOTIONAL DISTRESS 3 0.0000
789 DYSKINESIA 1 0.0000
790 ERYTHEMA 5 0.0000
791 CARDIAC ARREST 2 0.0000
792 CARDIO-RESPIRATORY ARREST 1 0.0000
793 OSTEOARTHRITIS 1 0.0000
794 VAGINAL HAEMORRHAGE 1 0.0000
795 MENTAL DISORDER 1 0.0000
796 THROAT IRRITATION 1 0.0000
797 HYPOKALAEMIA 1 0.0000
798 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
799 BLOOD CHOLESTEROL INCREASED 1 0.0000
800 COMA 1 0.0000
801 RENAL CANCER 1 0.0000
802 MIGRAINE 2 0.0000
803 PRODUCTIVE COUGH 1 0.0000
804 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
805 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
806 ECZEMA 1 0.0000
807 PANCREATITIS 1 0.0000
808 DISTURBANCE IN ATTENTION 1 0.0000
809 OXYGEN SATURATION DECREASED 1 0.0000
810 EYE PAIN 1 0.0000
811 DYSPHONIA 1 0.0000
812 BLADDER CANCER 1 0.0000
813 WHEEZING 1 0.0000
814 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
815 IRRITABILITY 1 0.0000
816 NO ADVERSE EVENT 3 0.0000
817 SUICIDE ATTEMPT 1 0.0000
818 VERTIGO 1 0.0000
819 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
820 INTENTIONAL OVERDOSE 1 0.0000
821 DEEP VEIN THROMBOSIS 1 0.0000
822 PSORIASIS 2 0.0000
823 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
824 SKIN BURNING SENSATION 1 0.0000
825 ACNE 1 0.0000
826 CHRONIC KIDNEY DISEASE 1 0.0000
827 DIABETES MELLITUS 1 0.0000
828 TREATMENT FAILURE 1 0.0000
829 COMPLETED SUICIDE 1 0.0000
830 TACHYCARDIA 1 0.0000
831 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
832 PULMONARY EMBOLISM 1 0.0000
833 RHEUMATOID ARTHRITIS 1 0.0000
834 DRUG DOSE OMISSION 1 0.0000
835 INCORRECT DOSE ADMINISTERED 1 0.0000
836 CONDITION AGGRAVATED 1 0.0000